ArticleBritish journal of cancer2024

Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice.

Cornelius F Waller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.